High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects
Cited by 66
Related Papers
Autocrined leptin promotes proliferation of non-small cell lung cancer (NSCLC) via PI3K/AKT and p53 pathways
|Annals of Translational Medicine|2021|25
MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway
|EBioMedicine|2021|20
m<sup>6</sup>A‐dependent upregulation of DDX21 by super‐enhancer‐driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia
|Clinical and Translational Medicine|2024|20
miR-550-1 functions as a tumor suppressor in acute myeloid leukemia via the hippo signaling pathway
|International Journal of Biological Sciences|2020|18
Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation
|International Journal of Biological Sciences|2018|17